ArticleJournal of medicinal chemistry2024

Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.

Oscar Mammoliti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.